Historical shareholding details of
AllianceBernstein L.P.
holdings in Viking Therapeutics Inc (VKTX)
Monthly changes of
AllianceBernstein L.P.
shareholding in Viking Therapeutics Inc
over the previous
months
Month
|
Name |
Total no. shares held |
Percent Holding |
Mar 31, 2025
|
Alliancebernstein L.P.
|
581,052
|
0.52%
|
|
Feb 28, 2025
|
Alliancebernstein L.P.
|
581,052
|
0.52%
|
|
Jan 31, 2025
|
Alliancebernstein L.P.
|
562,588
|
0.50%
|
|
Dec 31, 2024
|
Alliancebernstein L.P.
|
1,115,068
|
0.99%
|
Dec 31, 2024
|
Alliancebernstein L.P.
|
579,061
|
0.52%
|
|
Nov 30, 2024
|
Alliancebernstein L.P.
|
567,229
|
0.51%
|
|
Oct 31, 2024
|
Alliancebernstein L.P.
|
580,974
|
0.52%
|
|
Sep 30, 2024
|
Alliancebernstein L.P.
|
1,033,885
|
0.93%
|
Sep 30, 2024
|
Alliancebernstein L.P.
|
591,014
|
0.53%
|
|
Aug 31, 2024
|
Alliancebernstein L.P.
|
611,613
|
0.55%
|
|
Jul 31, 2024
|
Alliancebernstein L.P.
|
700,316
|
0.63%
|
|
Jun 30, 2024
|
Alliancebernstein L.P.
|
1,241,125
|
1.11%
|
Jun 30, 2024
|
Alliancebernstein L.P.
|
816,863
|
0.74%
|
|
May 31, 2024
|
Alliancebernstein L.P.
|
829,243
|
0.75%
|
|
Apr 30, 2024
|
Alliancebernstein L.P.
|
928,676
|
0.84%
|
|
Mar 31, 2024
|
Alliancebernstein L.P.
|
1,560,878
|
1.41%
|
Mar 31, 2024
|
Alliancebernstein L.P.
|
928,676
|
0.84%
|
|
Feb 29, 2024
|
Alliancebernstein L.P.
|
2,086,328
|
2.08%
|
|
Jan 31, 2024
|
Alliancebernstein L.P.
|
2,085,159
|
2.08%
|
|
Dec 31, 2023
|
Alliancebernstein L.P.
|
3,673,935
|
3.33%
|
Dec 31, 2023
|
Alliancebernstein L.P.
|
2,107,702
|
2.11%
|
|
Nov 30, 2023
|
Alliancebernstein L.P.
|
1,966,488
|
1.97%
|
|
Oct 31, 2023
|
Alliancebernstein L.P.
|
1,966,488
|
1.97%
|
|
Sep 30, 2023
|
Alliancebernstein L.P.
|
3,550,074
|
3.53%
|
Sep 30, 2023
|
Alliancebernstein L.P.
|
1,817,602
|
1.82%
|
|
Aug 31, 2023
|
Alliancebernstein L.P.
|
1,817,602
|
1.82%
|
|
Jul 31, 2023
|
Alliancebernstein L.P.
|
1,647,917
|
1.65%
|
|
Jun 30, 2023
|
Alliancebernstein L.P.
|
2,961,561
|
2.96%
|
|
Mar 31, 2023
|
Alliancebernstein L.P.
|
13,656
|
0.01%
|
View all ownership details of Viking Therapeutics Inc